How to Help Your Patients Find Mycophenolic Acid in Stock: A Provider's Guide

For transplant coordinators and prescribing physicians, a call from a patient who cannot fill their mycophenolate prescription is a high-stakes situation. Unlike most medications where a missed dose is an inconvenience, interruptions in immunosuppression therapy can trigger organ rejection. Having a clear, practiced protocol for these situations is not optional—it's essential to patient safety.

This guide provides practical, actionable steps for transplant programs and prescribers to help patients quickly locate mycophenolate mofetil (CellCept) or mycophenolate sodium (Myfortic) when their usual pharmacy is out of stock.

Step 1: Triage the Urgency of the Request

Not all "out of stock" calls carry the same urgency. Your first question should be: "How many doses do you have remaining?" A patient who has 5 days of medication left has more time to locate a solution than one who has 1 dose left.

0–1 doses remaining: Activate emergency protocols immediately. Contact your center's specialty pharmacy for same-day dispensing. Consider temporary bridge therapy if needed.

2–3 days remaining: Actively search for alternative pharmacies in the patient's area; consider directing to medfinder or your center's preferred specialty pharmacy.

4+ days remaining: Help patient identify alternatives before stock runs out; still treat as urgent.

Step 2: Know Your Center's Specialty Pharmacy Resources

Most transplant centers work with one or more specialty pharmacies that stock immunosuppressants reliably. Transplant coordinators should have these contact numbers readily available and should know each pharmacy's hours, delivery capabilities, and whether they can dispense emergency supplies.

Critically, specialty pharmacies that serve transplant populations typically maintain deeper inventory of both mycophenolate mofetil and mycophenolate sodium than general retail pharmacies, because they know their customer base depends on consistent supply.

Step 3: Recommend medfinder for Patients Who Can't Get to Your Specialty Pharmacy

For patients who cannot access your center's specialty pharmacy—due to geography, transportation barriers, or after-hours situations—medfinder is a valuable resource. medfinder calls pharmacies near the patient to check which ones have the specific medication and strength in stock, then texts the patient the results. This eliminates the time-consuming process of patients calling pharmacy after pharmacy from home.

Consider adding medfinder to your patient discharge materials and patient education resources as a go-to tool for medication availability issues.

Step 4: Understand Formulation Conversion if Needed

If a patient cannot obtain their specific formulation and an alternative pharmacy isn't feasible within the necessary timeframe, a temporary formulation switch may be required. Key clinical points:

MMF → EC-MPS: 1,000 mg MMF twice daily → 720 mg EC-MPS twice daily. Monitor for changes in GI tolerability (EC-MPS typically causes fewer upper GI symptoms).

EC-MPS → MMF: 720 mg EC-MPS twice daily → 1,000 mg MMF twice daily. Counsel patients that the absorption profile differs; MMF should be taken on an empty stomach.

When cyclosporine is the concomitant calcineurin inhibitor (rather than tacrolimus), plasma MPA AUC may be lower due to cyclosporine's inhibition of OATP transporters involved in enterohepatic recirculation of MPA. This is clinically important when comparing MPA exposure across regimens.

Step 5: Document and Follow Up

Any time a patient experiences a medication access issue, document it in the chart. If a formulation change was required, schedule a follow-up visit or phone check-in to:

Confirm the patient successfully filled their prescription

Check for any new GI symptoms or adverse effects from the formulation change

Review labs (CBC, creatinine, drug levels if applicable)

Address any adherence concerns that arose from the supply disruption

Proactive Patient Education to Prevent Supply Crises

The best time to address medication access issues is before they happen. Consider adding these elements to your transplant patient education program:

Instruct all transplant patients to refill prescriptions 5–7 days before running out

Encourage use of 90-day fills where possible to reduce refill frequency

Include medfinder in your post-transplant resource packet as a medication-finding tool

Provide clear after-hours contact information so patients know who to call if a supply problem arises on a weekend or holiday

For more clinical background on the shortage landscape, see our companion article: Mycophenolic Acid Shortage: What Providers and Prescribers Need to Know in 2026.